Cargando…

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma

To discover distinct immune responses promoting or inhibiting hepatocellular carcinoma (HCC), we perform a three-dimensional analysis of the immune cells, correlating immune cell types, interactions, and changes over time in an animal model displaying gender disparity in nonalcoholic fatty liver dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirshahi, Faridoddin, Aqbi, Hussein F., Isbell, Madison, Manjili, Saeed H., Guo, Chunqing, Saneshaw, Mulugeta, Bandyopadhyay, Dipankar, Dozmorov, Mikhail, Khosla, Archit, Wack, Katy, Carrasco-Zevallos, Oscar M., Idowu, Michael O., Wang, Xiang-Yang, Sanyal, Arun J., Manjili, Masoud H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028248/
https://www.ncbi.nlm.nih.gov/pubmed/35235789
http://dx.doi.org/10.1016/j.celrep.2022.110454
_version_ 1784691568984195072
author Mirshahi, Faridoddin
Aqbi, Hussein F.
Isbell, Madison
Manjili, Saeed H.
Guo, Chunqing
Saneshaw, Mulugeta
Bandyopadhyay, Dipankar
Dozmorov, Mikhail
Khosla, Archit
Wack, Katy
Carrasco-Zevallos, Oscar M.
Idowu, Michael O.
Wang, Xiang-Yang
Sanyal, Arun J.
Manjili, Masoud H.
author_facet Mirshahi, Faridoddin
Aqbi, Hussein F.
Isbell, Madison
Manjili, Saeed H.
Guo, Chunqing
Saneshaw, Mulugeta
Bandyopadhyay, Dipankar
Dozmorov, Mikhail
Khosla, Archit
Wack, Katy
Carrasco-Zevallos, Oscar M.
Idowu, Michael O.
Wang, Xiang-Yang
Sanyal, Arun J.
Manjili, Masoud H.
author_sort Mirshahi, Faridoddin
collection PubMed
description To discover distinct immune responses promoting or inhibiting hepatocellular carcinoma (HCC), we perform a three-dimensional analysis of the immune cells, correlating immune cell types, interactions, and changes over time in an animal model displaying gender disparity in nonalcoholic fatty liver disease (NAFLD)-associated HCC. In response to a Western diet (WD), animals mount acute and chronic patterns of inflammatory cytokines, respectively. Tumor progression in males and females is associated with a predominant CD8(+ >) CD4(+), Th1 > Th17 > Th2, NKT > NK, M1 > M2 pattern in the liver. A complete rescue of females from HCC is associated with an equilibrium Th1 = Th17 = Th2, NKT = NK, M1 = M2 pattern, while a partial rescue of males from HCC is associated with an equilibrium CD8(+) = CD4(+), NKT = NK and a semi-equilibrium Th1 = Th17 > Th2 but a sustained M1 > M2 pattern in the liver. Our data suggest that immunological pattern-recognition can explain immunobiology of HCC and guide immune modulatory interventions for the treatment of HCC in a gender-specific manner.
format Online
Article
Text
id pubmed-9028248
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-90282482022-04-22 Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma Mirshahi, Faridoddin Aqbi, Hussein F. Isbell, Madison Manjili, Saeed H. Guo, Chunqing Saneshaw, Mulugeta Bandyopadhyay, Dipankar Dozmorov, Mikhail Khosla, Archit Wack, Katy Carrasco-Zevallos, Oscar M. Idowu, Michael O. Wang, Xiang-Yang Sanyal, Arun J. Manjili, Masoud H. Cell Rep Article To discover distinct immune responses promoting or inhibiting hepatocellular carcinoma (HCC), we perform a three-dimensional analysis of the immune cells, correlating immune cell types, interactions, and changes over time in an animal model displaying gender disparity in nonalcoholic fatty liver disease (NAFLD)-associated HCC. In response to a Western diet (WD), animals mount acute and chronic patterns of inflammatory cytokines, respectively. Tumor progression in males and females is associated with a predominant CD8(+ >) CD4(+), Th1 > Th17 > Th2, NKT > NK, M1 > M2 pattern in the liver. A complete rescue of females from HCC is associated with an equilibrium Th1 = Th17 = Th2, NKT = NK, M1 = M2 pattern, while a partial rescue of males from HCC is associated with an equilibrium CD8(+) = CD4(+), NKT = NK and a semi-equilibrium Th1 = Th17 > Th2 but a sustained M1 > M2 pattern in the liver. Our data suggest that immunological pattern-recognition can explain immunobiology of HCC and guide immune modulatory interventions for the treatment of HCC in a gender-specific manner. 2022-03-01 /pmc/articles/PMC9028248/ /pubmed/35235789 http://dx.doi.org/10.1016/j.celrep.2022.110454 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Mirshahi, Faridoddin
Aqbi, Hussein F.
Isbell, Madison
Manjili, Saeed H.
Guo, Chunqing
Saneshaw, Mulugeta
Bandyopadhyay, Dipankar
Dozmorov, Mikhail
Khosla, Archit
Wack, Katy
Carrasco-Zevallos, Oscar M.
Idowu, Michael O.
Wang, Xiang-Yang
Sanyal, Arun J.
Manjili, Masoud H.
Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
title Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
title_full Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
title_fullStr Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
title_full_unstemmed Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
title_short Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
title_sort distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028248/
https://www.ncbi.nlm.nih.gov/pubmed/35235789
http://dx.doi.org/10.1016/j.celrep.2022.110454
work_keys_str_mv AT mirshahifaridoddin distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT aqbihusseinf distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT isbellmadison distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT manjilisaeedh distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT guochunqing distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT saneshawmulugeta distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT bandyopadhyaydipankar distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT dozmorovmikhail distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT khoslaarchit distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT wackkaty distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT carrascozevallososcarm distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT idowumichaelo distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT wangxiangyang distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT sanyalarunj distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma
AT manjilimasoudh distincthepaticimmunologicalpatternsareassociatedwiththeprogressionorinhibitionofhepatocellularcarcinoma